Daniel Zingg

Daniel Zingg is an experienced professional in the field of medical affairs, specializing in vascular diseases and knowledge management. Currently serving as the Global Medical Affairs Lead at OM Pharma since October 2020, Daniel has previously held similar leadership roles at Vifor Pharma from January 2011 to September 2020, focusing on immunomodulation and diseases associated with microcirculation dysregulation. With earlier positions in medical and scientific affairs at Solvay Pharmaceuticals and sanofi-aventis, Daniel also brings expertise in regulatory affairs and diverse therapeutic areas including infectiology, urogynecology, and neurology. Daniel holds a Diploma of Advanced Studies in Pharmaceutical Medicine from the University of Basel and a PhD in Radio-Oncology from ETH Zürich, complemented by a Master's degree in Biology from the same institution.